US equities |
SPCX $168.91 ▲+6.26% NVDA $237.86 ▲+1.67% MU $1,063.63 ▼-1.05% TSLA $379.61 ▲+2.43% MSFT $525.25 ▲+1.49% SNDK $1,713.68 ▼-0.37% INTC $117.11 ▼-1.86% META $743.96 ▲+2.18%
FinancialContent

Globus Medical, Inc. Class A Common Stock (NY:GMED)

76.59 +0.99 (+1.30%)
Delayed Quote Updated: 1:45 PM EDT, Oct 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Globus Medical, Inc. Class A Common Stock

< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >
News headline image
The Analyst Verdict: Globus Medical In The Eyes Of 6 Experts ↗
 
Via Benzinga
News headline image
Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results
From Globus Medical
Via GlobeNewswire
News headline image
NYSE:GMED qualifies as a high growth stock and is consolidating. ↗
GLOBUS MEDICAL INC - A (NYSE:GMED)—A High-Growth Stock Gearing Up for Its Next Upward Move. 
Via Chartmill
News headline image
Investors seeking growth at a reasonable cost should explore NYSE:GMED. ↗
In the world of growth stocks, NYSE:GMED shines as a value proposition. 
Via Chartmill
News headline image
Assessing Globus Medical: Insights From 5 Financial Analysts ↗
 
Via Benzinga
News headline image
NYSE:GMED: a strong growth stock preparing for the next leg up?. ↗
GLOBUS MEDICAL INC - A (NYSE:GMED) qualifies as a high growth stock and is consolidating. 
Via Chartmill
News headline image
Expert Ratings for Globus Medical ↗
 
Via Benzinga
News headline image
Globus Medical: Q3 Earnings Insights ↗
 
Via Benzinga
News headline image
NYSE:GMED is showing good growth, while it is not too expensive. ↗
NYSE:GMED, a growth stock which is not overvalued. 
Via Chartmill
News headline image
3 Stocks at the Forefront of Medical Robotics ↗
Although the concept of medical robotics stocks is incredibly risky, the sector also offers tremendous upside for the intrepid. 
Via InvestorPlace
News headline image
For those who appreciate growth without the sticker shock, NYSE:GMED is worth considering. ↗
GLOBUS MEDICAL INC - A (NYSE:GMED) is not too expensive for the growth it is showing. 
Via Chartmill
News headline image
Investors should take note of NYSE:GMED, a growth stock that remains attractively priced. ↗
Despite its growth, NYSE:GMED remains within the realm of affordability. 
Via Chartmill
News headline image
Globus Medical (GMED) Q3 2023 Earnings Call Transcript ↗
GMED earnings call for the period ending September 30, 2023. 
Via The Motley Fool
Topics Earnings
News headline image
Globus Medical Reports Third Quarter 2023 Results
From Globus Medical
Via GlobeNewswire
News headline image
What 8 Analyst Ratings Have To Say About Globus Medical ↗
 
Via Benzinga
News headline image
The Latest Analyst Ratings for Globus Medical ↗
 
Via Benzinga
News headline image
Where Globus Medical Stands With Analysts ↗
 
Via Benzinga
News headline image
Globus Medical (GMED) Q2 2023 Earnings Call Transcript ↗
GMED earnings call for the period ending June 30, 2023. 
Via The Motley Fool
News headline image
Globus Medical Schedules Third Quarter Earnings Release and Conference Call
From Globus Medical
Via GlobeNewswire
News headline image
Five-Year Study Outcomes of the NuVasive Simplify Cervical Disc were Presented at the North American Spine Society 38th Annual Meeting
From Globus Medical
Via GlobeNewswire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For October 20, 2023 ↗
 
Via Benzinga
News headline image
Twenty Years of the NuVasive XLIF Procedure Celebrated at the Society for Minimally Invasive Spine Surgery 2023 Annual Forum
From Globus Medical
Via GlobeNewswire
News headline image
Globus Medical and NuVasive to Sponsor and Participate at EUROSPINE 2023
From Globus Medical
Via GlobeNewswire
News headline image
Globus Medical's Untapped Potential Beyond The NUVA Transaction; Analyst Turns Bullish ↗
Stifel analyst Mathew Blackman upgraded Globus Medical, Inc. (NYSE: GMED) to Buy from Hold, 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For September 19, 2023 ↗
 
Via Benzinga
News headline image
NuVasive Specialized Orthopedics Launches Precice Bone Transport in International Markets
From Globus Medical
Via GlobeNewswire
News headline image
Globus Medical Completes Merger with NuVasive
From Globus Medical
Via GlobeNewswire
News headline image
Globus Medical Reports Second Quarter 2023 Results
From Globus Medical
Via GlobeNewswire
News headline image
Globus Medical Announces Launch of the MARVEL™ Growing Rod System, the company’s first product designed specifically for early onset scoliosis
MARVEL™ is Globus Medical’s second major release this year in the pediatric scoliosis space 
From Globus Medical
Via GlobeNewswire
News headline image
Globus Medical Schedules Second Quarter Earnings Release and Conference Call
From Globus Medical
Via GlobeNewswire
< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >